Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Warangkana, Munsakul"'
Autor:
Benjamas Baipluthong, Thanomsak Anekthananon, Warangkana Munsakul, Supunnee Jirajariyavej, Suvanna Asavapiriyanont, Ubonsri Hancharoenkit, Anuvat Roongpisuthipong, Sarika Pattanasin, Michael Martin, Lisa Guntamala, Rangsima Lolekha
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0170558 (2017)
BACKGROUND:We implemented a hospital-based prevention with positives (PwP) intervention among people living with HIV (PLHIV) that included HIV transmission risk screening, short HIV prevention messages, family planning, HIV disclosure counseling, and
Externí odkaz:
https://doaj.org/article/9d21e4151ffb4f4d80d1727be8c7eee9
Autor:
Warangkana Munsakul1, Rangsima Lolekha2 hpu8@cdc.gov, Boonchai Kowadisaiburana3, Anuvat Roongpisuthipong4, Supannee Jirajariyavej5, Suvanna Asavapiriyanont6, Ubonsri Hancharoenkit7, Benjamas Baipluthong2, Sarika Pattanasin2, Martin, Michael2,8
Publikováno v:
Reproductive Health. 2/3/2016, p1-11. 11p. 1 Diagram, 3 Charts.
Autor:
Suvanna Asavapiriyanont, Benjamas Baipluthong, Anuvat Roongpisuthipong, Ubonsri Hancharoenkit, Lisa Guntamala, Supunnee Jirajariyavej, Sarika Pattanasin, Rangsima Lolekha, Michael Martin, Warangkana Munsakul, Thanomsak Anekthananon
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 2, p e0170558 (2017)
PLoS ONE, Vol 12, Iss 2, p e0170558 (2017)
Background We implemented a hospital-based prevention with positives (PwP) intervention among people living with HIV (PLHIV) that included HIV transmission risk screening, short HIV prevention messages, family planning, HIV disclosure counseling, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::facf5ffaee2ad72a5e5fb8df04471144
http://europepmc.org/articles/PMC5291364
http://europepmc.org/articles/PMC5291364
Autor:
Warangkana Munsakul
Vajira Medical Journal, 60, 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d4b6d5b2f6d5da164b73e9c4f71c74
Autor:
Somboon Tansuphasawasdikul, Ploenchan Chetchotisakd, Jintanat Anaworanich, Phitsanu Raksakulkarn, Wisit Prasithsirikul, Sasisopin Kiertiburanakul, Kiat Ruxrungtham, Warangkana Munsakul, Sineenart Chautrakarn, Bernard Hirschel, Reto Nüesch, Angèle Gayet-Ageron
Publikováno v:
The Open AIDS Journal, Vol. 3 (2009) pp. 38-45
The Open AIDS Journal
The Open AIDS Journal
Objective:Investigation on anxiety, stress, depression, and quality of life (QoL) within STACCATO, a randomised trial of two treatment strategies: CD4 guided scheduled treatment interruption (STI) compared to continuous treatment (CT).Participants:Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0aeb46f5c5819899098d02f27ddb973
https://doi.org/10.2174/1874613600903010038
https://doi.org/10.2174/1874613600903010038
Autor:
Tanakorn Apornpong, Ploenchan Chetchotisakd, Pacharee Kantipong, Anchalee Avihingsanon, Chureeratana Bowonwatanuwong, Sripetcharat Mekviwattanawong, Praphan Phanuphak, Stephen J. Kerr, Niramon Leerattanapetch, Supunnee Jirajariyavej, Sireethorn Nimitvilai, Warangkana Munsakul, Sasisopin Kiertiburanakul, Virat Klinbuayaem, Sukit Banchongkit, Kiat Ruxrungtham, Malee Techapornroong, Suchada Chaivooth, Sorakij Bhakeecheep, Wisit Prasithsirikul, David A. Cooper, Torsak Bunupuradah, Sean Emery
Publikováno v:
Lancet HIV, 3(8), e343-e350. Elsevier Limited
Summary Background Thai patients with HIV have higher exposure to HIV protease inhibitors than do white people and dose reduction might be possible. We compared the efficacy of low-dose with standard-dose ritonavir-boosted atazanavir in virologically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7267ddad29f9481b575201920aac38
https://pubmed.ncbi.nlm.nih.gov/27470020
https://pubmed.ncbi.nlm.nih.gov/27470020
Autor:
Ploenchan Chetchotisakd, Reto Nüesch, Claudette S. Satchell, David A. Cooper, Warangkana Munsakul, Kiat Ruxrungtham, Michelle Le Braz, Enos Bernasconi, Daniel Genné, Jintanat Ananworanich, Phitsanu Raksakulkarn, Sabine Yerly, Praphan Phanuphak, Urs Karrer, Matthias Cavassini, Dominic Leduc, Sunee Sirivichayakul, Andrew Hill, Wisit Prasithsirikul, Angèle Gayet-Ageron, Bernard Hirschel, Hansjakob Furrer, Sasisopin Kiertiburanakul, Thomas V. Perneger, Somboon Tansuphasawasdikul, Luc Perrin, Pietro Vernazza
Publikováno v:
The Lancet, Vol. 368, No 9534 (2006) pp. 459-465
Lancet, 368(9534), 459-465. Elsevier Limited
Lancet, 368(9534), 459-465. Elsevier Limited
BACKGROUND: Stopping antiretroviral therapy in patients with HIV-1 infection can reduce costs and side-effects, but carries the risk of increased immune suppression and emergence of resistance. METHODS: 430 patients with CD4-positive T-lymphocyte (CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4730eee4a10a5ffd3297ba75baf6565
https://doi.org/10.1016/s0140-6736(06)69153-8
https://doi.org/10.1016/s0140-6736(06)69153-8
Autor:
Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604
https://doi.org/10.1177/135965350501000604
Autor:
Chureeratana Bowonwattanuwong, Torsak Bunupuradah, Warangkana Munsakul, Supunnee Jirajariyavej, Kiat Ruxrungtham, Apicha Mahanontharit, Jintanat Ananworanich, Jiratchaya Sophonphan, Virat Klinbuayaem, Bernard Hirschel
Publikováno v:
Antiviral therapy. 19(6)
Background HIV-1 shedding in genital secretions is associated with HIV transmission risk. Limited data exist on the effect of second-line lopinavir/ritonavir mono-therapy (mLPV/r) on genital secretion of HIV RNA. Methods We measured HIV-1 in genital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8657dc9573cf1bc93089c38a2ff690fc
https://pubmed.ncbi.nlm.nih.gov/24464590
https://pubmed.ncbi.nlm.nih.gov/24464590
Autor:
Victor Valcour, Supunnee Jirajariyavej, Ploenchan Chetchotisakd, Virat Klinbuayaem, Warangkana Munsakul, Kiat Ruxrungtham, Wisit Prasithsirikul, Sorakij Bhakeecheep, Chureeratana Bowonwattanuwong, Bernard Hirschel, Apicha Mahanontharit, Jiratchaya Sophonphan, Jintanat Ananworanich, Torsak Bunupuradah
Publikováno v:
Journal of neurovirology. 18(6)
We compared rates of neurocognitive impairment (NCI) among 93 Thai adults failing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based combination antiretroviral therapy (cART) before and after switching to lopinavir/ritonavir monotherapy (mL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30739f7f0cb9ea6df1b6ceb73732ada3
https://pubmed.ncbi.nlm.nih.gov/22993101
https://pubmed.ncbi.nlm.nih.gov/22993101